Dapagliflozin inhibits ferroptosis to improve chronic heart failure by regulating Nrf2/HO-1/GPX4 signaling pathway. Zhang J, Chen X, Lv S, Hao Q, et al. PLoS One 2025;20:e0317295.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang J, Chen X, Lv S, Hao Q, et al. Dapagliflozin inhibits ferroptosis to improve chronic heart failure by regulating Nrf2/HO-1/GPX4 signaling pathway. PLoS One 2025;20:e0317295.
PMID: 39874368